{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:51Z","timestamp":1786982211806,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T00:00:00Z","timestamp":1474675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003194","name":"Agent\u00fara Ministerstva \u0161kolstva, vedy, v\u00fdskumu a \u0161portu SR","doi-asserted-by":"publisher","award":["01ED1201A"],"award-info":[{"award-number":["01ED1201A"]}],"id":[{"id":"10.13039\/501100003194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","award":["26240120033"],"award-info":[{"award-number":["26240120033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12035-016-0128-4","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T03:21:10Z","timestamp":1474687270000},"page":"5919-5927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review"],"prefix":"10.1007","volume":"54","author":[{"given":"Silvia","family":"Koscova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Zakova Slivarichova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Tomeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Melicherova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzbeta","family":"Janakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Kosorinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girma","family":"Belay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,24]]},"reference":[{"key":"128_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"issue":"5","key":"128_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00143119","volume":"7","author":"E Mitrov\u00e1","year":"1991","unstructured":"Mitrov\u00e1 E (1991) Some new aspects of CJD epidemiology in Slovakia. Eur J Epidem 7(5):439\u2013449","journal-title":"Eur J Epidem"},{"key":"128_CR3","first-page":"31","volume":"46","author":"E Mitrov\u00e1","year":"2002","unstructured":"Mitrov\u00e1 E, Belay G (2002) Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31\u201339","journal-title":"Acta Virol"},{"key":"128_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0753-3322(94)90057-4","volume":"48","author":"AD Korczyn","year":"1994","unstructured":"Korczyn AD (1994) Neurologic genetic diseases of Jewish people. Biomed Pharmacother 48:391\u2013397","journal-title":"Biomed Pharmacother"},{"key":"128_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-010-5738-6","volume":"258","author":"Z Meiner","year":"2011","unstructured":"Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J et al (2011) Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol 258:255\u2013262","journal-title":"J Neurol"},{"key":"128_CR6","unstructured":"WHO (2003) WHO manual for surveillance of human transmissible spongiform encephalopathies, including variant Creutzfeldt-Jakob disease, Geneva ISBN 92\u20134\u2013154588-7"},{"key":"128_CR7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"55","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F et al (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811\u2013815","journal-title":"Neurology"},{"key":"128_CR8","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668","journal-title":"Brain"},{"key":"128_CR9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S et al (2006) Determinatinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic CJD. Brain 129:2278\u20132287","journal-title":"Brain"},{"issue":"4","key":"128_CR10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","volume":"53","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M, Sklaviadis T, Laplanche JL et al (2016) Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic. Mol Neurobiol 53(4):2189\u20132199","journal-title":"Mol Neurobiol"},{"key":"128_CR11","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E et al (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10\u00a0years. Brain 135:3051\u20133061","journal-title":"Brain"},{"key":"128_CR12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","volume":"81","author":"G Chohan","year":"2010","unstructured":"Chohan G, Pennigton C, Mackenzie J, Andrews M, Everington D, Will R, Knight R, Green A (2010) The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81:1243\u20131248","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"128_CR13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","volume":"71","author":"E Kapaki","year":"2001","unstructured":"Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E (2001) Highly increased CSF tau-protein and decreased beta-amyloid (1-42) in sporadic CJD: discrimination from Alzheimer\u2019s disease? J Neurol Neurosurg Psychiatry 71(3):401\u2013403","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"128_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA et al (1997) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225(3):210\u2013212","journal-title":"Neurosci Lett"},{"issue":"2","key":"128_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1999.0730443.x","volume":"73","author":"DH Small","year":"1999","unstructured":"Small DH, McLean CA (1999) Alzheimer\u2019s disease and the amyloid beta protein: what is the role of amyloid? J Neurochem 73(2):443\u2013449","journal-title":"J Neurochem"},{"key":"128_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2377-11-133","volume":"11","author":"MB Coulthart","year":"2011","unstructured":"Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR (2011) Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 11:133","journal-title":"BMC Neurol"},{"key":"128_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretschmar HA et al (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32\u201340","journal-title":"Ann Neurol"},{"key":"128_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L et al (2002) Tau protein and 14-3-3 in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197","journal-title":"Neurology"},{"key":"128_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637\u2013643","journal-title":"Neurology"},{"key":"128_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340\u2013342","journal-title":"Nature"},{"key":"128_CR21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","volume":"256","author":"A Ladogana","year":"2009","unstructured":"Ladogana A, Sanchez Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A et al (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256:1620\u20131628","journal-title":"J Neurol"},{"key":"128_CR22","doi-asserted-by":"crossref","unstructured":"Skinningsrud A, Stenser V, Gundersen AS, Fladby T (2008) Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res 5","DOI":"10.1186\/1743-8454-5-14"},{"key":"128_CR23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00415-009-5160-0","volume":"256","author":"IE Baldeiras","year":"2009","unstructured":"Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira C (2009) Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J Neurol 256:1540\u20131550","journal-title":"J Neurol"},{"issue":"7","key":"128_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, Stoeck K, Sklaviadis T et al (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254(7):901\u2013906","journal-title":"J Neurol"},{"key":"128_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12441","author":"OS Cohen","year":"2015","unstructured":"Cohen OS, Chapman J, Korczyn AD, Warman-Alaluf N, Nitsan Z, Appel S, Kahana E, Rosenmann H (2015) CSF tau correlates with CJD severity and cognitive decline. Acta Neurol Scand . doi:\n10.1111\/ane.12441\n\nMay 25","journal-title":"Acta Neurol Scand"},{"key":"128_CR26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004010050870","volume":"96","author":"JA Hainfeller","year":"1998","unstructured":"Hainfeller JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 96:116\u2013122","journal-title":"Acta Neuropathol"},{"issue":"2","key":"128_CR27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10654-015-0049-y","volume":"31","author":"A Krasnianski","year":"2016","unstructured":"Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA et al (2016) Clinical findings and diagnosis in genetic prion disease in Germany. Eur J Epidemiol 31(2):187\u2013196","journal-title":"Eur J Epidemiol"},{"key":"128_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10571-006-9370-z","volume":"26","author":"K Satoh","year":"2006","unstructured":"Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Tsujihata M, Niwa M, Katamine S et al (2006) 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 26:45\u201352","journal-title":"Cell Mol Neurobiol"},{"key":"128_CR29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00415-011-5960-x","volume":"258","author":"M Noguchi-Shinohara","year":"2011","unstructured":"Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Sakai K, Yamada M (2011) Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease. J Neurol 258:1464\u20131468","journal-title":"J Neurol"},{"key":"128_CR30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","volume":"54","author":"M Otto","year":"2000","unstructured":"Otto M, Esselmann H, Schulz-Schaeffer W, Neumann N, Schr\u00f6ter A, Ratzka P, Cepek L, Zerr I et al (2000) Decreased \u03b2-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 54:1099\u20131102","journal-title":"Neurology"},{"issue":"7","key":"128_CR31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","volume":"85","author":"D Alcolea","year":"2015","unstructured":"Alcolea D, Mart\u00ednez-Lage P, S\u00e1nchez-Juan P, Olazar\u00e1n J, Ant\u00fanez C, Izagirre A, Ecay-Torres M, Estanga A et al (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85(7):626\u2013633","journal-title":"Neurology"},{"key":"128_CR32","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/ijms12096281","volume":"12","author":"G Zanusso","year":"2011","unstructured":"Zanusso G, Fiorini M, Ferrari S, Gajofatto A, Cagnin A, Galassi A, Richelli S, Monaco S (2011) Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. Int J Mol Sci 12:6281\u20136292","journal-title":"Int J Mol Sci"},{"issue":"5","key":"128_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","volume":"12","author":"F Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, Varges D, Schmidt C et al (2016) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement 12(5):577\u2013589","journal-title":"Alzheimers Dement"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0128-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T07:11:55Z","timestamp":1504509115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0128-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,24]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0128-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,24]]}}}